Growth Metrics

Welsis (WLSS) Asset Utilization Ratio (2022 - 2024)

Welsis' quarterly Asset Utilization Ratio came in at 1.36 in Q2 2024, up 407.76% year-on-year from 0.27 in Q3 2023, and down 2.52% quarter-over-quarter from 1.4 in Q1 2024.

Welsis has reported Asset Utilization Ratio for 3 years, with the latest figure at 1.36 in Q2 2024.

  • For the quarter ending Q2 2024, Asset Utilization Ratio rose 407.76% year-over-year to 1.36; the trailing twelve-month figure through Jun 2024 stood at 1.36 (up 407.76% YoY), and the FY2023 full-year result was 0.74, changed N/A from the prior year.
  • Asset Utilization Ratio for Q2 2024 stood at 1.36, down from 1.4 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 1.4 in Q1 2024, with the low at 0.07 in Q4 2022.
  • Average Asset Utilization Ratio over 3 years is 0.75, with a median of 0.97 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio reached 1337.26% in 2024, while the deepest fall reached 407.76% in 2024.
  • Tracing WLSS's Asset Utilization Ratio over 3 years: stood at 0.07 in 2022, then soared by 1308.23% to 1.05 in 2023, then increased by 29.57% to 1.36 in 2024.
  • The last three Asset Utilization Ratio figures came in at 1.36 (Q2 2024), 1.4 (Q1 2024), and 1.05 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 0.37
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 2.16
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.40
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.88
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.57
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.20
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 0.62
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 1.61
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.62
10 Welsis - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 1.36
Mar 31, 2024 1.40
Dec 31, 2023 1.05
Sep 30, 2023 0.97
Jun 30, 2023 0.27
Mar 31, 2023 0.10
Dec 31, 2022 0.07